321 related articles for article (PubMed ID: 15458778)
1. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
Elvin SJ; Williamson ED
Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
[TBL] [Abstract][Full Text] [Related]
3. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
[TBL] [Abstract][Full Text] [Related]
5. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.
Elvin SJ; Williamson ED
Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741
[No Abstract] [Full Text] [Related]
6. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.
Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X
Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
Gupta G; Khan AA; Rao DN
Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
[TBL] [Abstract][Full Text] [Related]
8. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
[TBL] [Abstract][Full Text] [Related]
9. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
[TBL] [Abstract][Full Text] [Related]
10. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
[TBL] [Abstract][Full Text] [Related]
11. Protection against anthrax and plague by a combined vaccine in mice and rabbits.
Ren J; Dong D; Zhang J; Zhang J; Liu S; Li B; Fu L; Xu J; Yu C; Hou L; Li J; Chen W
Vaccine; 2009 Dec; 27(52):7436-41. PubMed ID: 19635609
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.
Griffin K; Bedford R; Townson K; Phillpotts R; Funnell S; Morton M; Williamson D; Titball R
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):425-30. PubMed ID: 15708318
[TBL] [Abstract][Full Text] [Related]
14. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
Leary SE; Griffin KF; Galyov EE; Hewer J; Williamson ED; Holmström A; Forsberg A; Titball RW
Microb Pathog; 1999 Mar; 26(3):159-69. PubMed ID: 10089156
[TBL] [Abstract][Full Text] [Related]
15. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
Uppada SB; Bhat AA; Sah A; Donthamshetty RN
Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
[TBL] [Abstract][Full Text] [Related]
16. Immunisation against plague by transcutaneous and intradermal application of subunit antigens.
Eyles JE; Elvin SJ; Westwood A; Lebutt CS; Alpar HO; Somavarapu S; Williamson ED
Vaccine; 2004 Oct; 22(31-32):4365-73. PubMed ID: 15474730
[TBL] [Abstract][Full Text] [Related]
17. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
Tripathi V; Chitralekha KT; Bakshi AR; Tomar D; Deshmukh RA; Baig MA; Rao DN
Vaccine; 2006 Apr; 24(16):3279-89. PubMed ID: 16476510
[TBL] [Abstract][Full Text] [Related]
18. Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.
Elvin SJ; Eyles JE; Howard KA; Ravichandran E; Somavarappu S; Alpar HO; Williamson ED
Vaccine; 2006 May; 24(20):4433-9. PubMed ID: 16546306
[TBL] [Abstract][Full Text] [Related]
19. Prospects for new plague vaccines.
Feodorova VA; Corbel MJ
Expert Rev Vaccines; 2009 Dec; 8(12):1721-38. PubMed ID: 19943765
[TBL] [Abstract][Full Text] [Related]
20. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
